CL
Coloplast A/S
CLPBY · OTC
$6.79 -2.65% (-$0.19)
1M +4.50%
Market Cap 101.5B kr
P/E Ratio 36.82x
Div. Yield 5.15%
ROE 19.63%
Bulios Fair Price
$8.6
26.8% upside
Current Price
$6.79
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CLPBY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
52 /100
Fair P/E 36.82x
EV/EBITDA 10.37x
P/FCF 16.07x
Growth
40 /100
Stable EPS growth 11.73%
Rev. growth 5.16%
Book val. growth 24.89%
Profitability
93 /100
Strong Gross margin 64.75%
Net margin 10.18%
FCF margin 23.34%
Quality
83 /100
Excellent ROIC 59.76%
ROE 19.63%
Asset turnover 0.58x
Debt
61 /100
Moderate Debt/Equity 1.78x
Current ratio 1.56x
Net debt/EBITDA 1.91x
Stability
93 /100
Stable Beta 0.53x
Rev. volatility 7.15%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CLPBY
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Gavin Wood
Employees
16,907
Headquarters
Humlebæk
Upcoming events
03 NOV
Earnings
Upcoming earnings report